Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00879996 · ClinicalTrials.gov registry record · Phase 4
Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients
A Phase 4 study, sponsored by State University of New York at Buffalo.
- Completed
- Registry status
- Phase 4
- Development phase
- 54
- Enrollment target
NCT00879996 is a Phase 4 study that has completed, run by State University of New York at Buffalo. The registered enrollment target is 54 participants.
The verdict
NCT00879996, a Phase 4 study, has completed, sponsored by State University of New York at Buffalo.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 54 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if buprenorphine or methadone is better for the treatment of chronic pain among patients who have become addicted to prescription narcotics.
Interventions
- DRUG Methadone
- DRUG Buprenorphine/naloxone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2009-04 |
| Est. Completion | 2011-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00879996
The ClinicalTrials.gov registry entry for NCT00879996 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York at Buffalo, which has 243 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Methadone is the first listed.
NCT00879996 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00879996 about?
NCT00879996 is a clinical study titled "Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients". The purpose of this study is to determine if buprenorphine or methadone is better for the treatment of chronic pain among patients who have become addicted to prescription narcotics.
What is the current status of trial NCT00879996?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 54 participants. The study started on 2009-04. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00879996?
The interventions under investigation include: Methadone (DRUG), Buprenorphine/naloxone (DRUG).
Who is sponsoring clinical trial NCT00879996?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.